Subspecialty	Gastroenterology , Liver Transplantation
Gender	Female
E-mail	charissa.chang@mssm.edu
Education and Training	MD, University of Maryland
	Residency, Internal Medicine, Boston University Medical Center
	Fellowship, Hepatology, Mount Sinai Hospital
	Fellowship, Gastroenterology, University of Virginia Health System
Awards	2005 Advanced Hepatology Fellowship Grant American Association of Liver Diseases
	1994 Research and Excellence Provost's Award for Undergraduate Johns Hopkins University, Baltimore, Maryland
	1994 Tau Beta Pi Engineering Honor Society Johns Hopkins University
	1991 Westinghouse Science Talent Search Semifinalist

Education and Training	MD, University of Maryland
	Residency, Internal Medicine, Boston University Medical Center
	Fellowship, Hepatology, Mount Sinai Hospital
	Fellowship, Gastroenterology, University of Virginia Health System
Board Certification	Gastroenterology

Subspecialty	Gastroenterology , Liver Transplantation
Board Certification	Gastroenterology

Research

• Portal Hypertension
• Treatment of Viral Hepatits
• Fatty Liver, NASH

Martin P, Chang C. Update on the United States Hepatitis B Treatment Algorithm. Current Hepatitis Reports 2007;.

Chang C, Singal A, Emre S, Schiano T, Lookstein R, Ganeshan S. Successful Use of Splenic Artery Embolization to Relieve Tense Ascites Following Liver Transplantation in a Patient with Budd Chiari Syndrome, Paroxysmal Nocturnal Hemoglobinuria, and Portal Vein Thrombosis: A Case Report. Liver Transplantation 2007; 13(11): 1532-1537.

Schiano T, Chang C. Drug Hepatototoxicity Update. Alimentary Pharmacology and Therapeutics 2007; 25(10): 1135-1151.

Caldwell S, Macik G, Chang C. Recombinant Activated Factor VII (rFVIIa) as a Hemostatic Agent in Liver Disease: A Break from Convention in Need of Controlled Trials. Hepatology 2004; 39(3): 592-598.

Caldwell S, Krugner-Higby L, Nakamoto R, Chang C. The Mitochondria in Non-Alcoholic Fatty Liver Disease. Clinics in Liver Disease 2004; 8(3): 595-617.

Chang C, Argo C, , Caldwell S, Al-Osaimi A. Antioxidant Therapy in Non-Alcoholic Fatty Liver Disease. J Clin Gastroenterol 2005; 39(suppl 4).

Caldwell S, Chang C, Nakamoto R, Krugner-Higby L. Enlarged hepatocytes in NAFLD examined with osmium fixation: does microsteatosis underlie cellular ballooning in NASH?. Clinics in Liver Disease 2004; 8(3): 595-617.